{
  "id": 1786,
  "text": "6 7 } }$ ( $) 5 \\% \\mathrm { C I } = 0 .4 6 { - 0 .9 9 }$ ), $\\mathrm { p } = 0 .0 4 5 ^ { \\cdot }$ ).It should be noted that (1) responses rates were $9 \\%$ and $5 \\%$ for pazopanib and lapatinib, respectively, and (2) the final analysis1666 confirmed the improvement in PFS with pazopanib compared with lapatinib but the improvement in OS lost its statistical significance $[ \\mathrm { H R } = 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 6 7 } }$ ( $) 5 \\% \\mathrm { C I } = 0 .4 6 { - 0 .9 9 }$ ), $\\mathrm { p } = 0 .0 4 5 ^ { \\cdot }$ ).It should be noted that (1) responses rates were $9 \\%$ and $5 \\%$ for pazopanib and lapatinib, respectively, and (2) the final analysis1666 confirmed the improvement in PFS with pazopanib compared with lapatinib but the improvement in OS lost its statistical significance $[ \\mathrm { H R } = 0 .\n\n<question>: ",
  "ChatGPT_response_0": "根据这项研究结果，可以得出使用帕唑帕尼比拉帕替尼在患者生存时间和疾病进展方面都表现更好的结论。另外，该研究还指出帕唑帕尼的有效反应率高于拉帕替尼。需要注意的是，尽管在 PFS 方面帕唑帕尼相较于拉帕替尼有显著改善，但其在 OS 方面的改善失去了统计学意义。",
  "query": "这项研究结果能告诉我们什么？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这项研究结果能告诉我们什么？\n\n<reference text>: 6 7 } }$ ( $) 5 \\% \\mathrm { C I } = 0 .4 6 { - 0 .9 9 }$ ), $\\mathrm { p } = 0 .0 4 5 ^ { \\cdot }$ ).It should be noted that (1) responses rates were $9 \\%$ and $5 \\%$ for pazopanib and lapatinib, respectively, and (2) the final analysis1666 confirmed the improvement in PFS with pazopanib compared with lapatinib but the improvement in OS lost its statistical significance $[ \\mathrm { H R } = 0 .\n\n<reply>: ",
  "response": "根据这项研究结果，可以得出使用帕唑帕尼比拉帕替尼在患者生存时间和疾病进展方面都表现更好的结论。另外，该研究还指出帕唑帕尼的有效反应率高于拉帕替尼。需要注意的是，尽管在 PFS 方面帕唑帕尼相较于拉帕替尼有显著改善，但其在 OS 方面的改善失去了统计学意义。"
}